Feasibility and efficacy of speed-feedback therapy with a bicycle ergometer on cognitive function in elderly cancer patients in Japan

Psycho-Oncology

Volumn 23, Issue 8, 2014, Pages 906-913

  Miki, Emi ^a   Kataoka, Tsuyoshi ^a   Okamura, Hitoshi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

cancer; cognitive function; elderly; rehabilitation; speed feedback therapy

Indexed keywords

AGED; ARTICLE; BARTHEL INDEX; BICYCLE ERGOMETER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL EFFECTIVENESS; COGNITION; COGNITIVE DEFECT; COGNITIVE REHABILITATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISTRESS SYNDROME; EMPLOYMENT STATUS; EXERCISE; FEASIBILITY STUDY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HEALTH STATUS; HUMAN; LAWTON INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE; MAJOR CLINICAL STUDY; MALE; PATIENT HISTORY OF THERAPY; PRIMARY TUMOR; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SPEED FEEDBACK THERAPY; ADAPTIVE BEHAVIOR; BREAST NEOPLASMS; COGNITION DISORDERS; COMPLICATION; CYCLING; EXERCISE TEST; JAPAN; KINESIOTHERAPY; NEUROPSYCHOLOGICAL TEST; PROCEDURES; PROSTATIC NEOPLASMS; PSYCHOLOGY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BICYCLING; BREAST NEOPLASMS; COGNITION; COGNITION DISORDERS; EXERCISE TEST; EXERCISE THERAPY; FEASIBILITY STUDIES; FEEDBACK, PSYCHOLOGICAL; FEMALE; HUMANS; JAPAN; MALE; NEUROPSYCHOLOGICAL TESTS; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 84905092887     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3501     Document Type: Article

References (25)

1. Extermann M, Hurria A,. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007; 25: 1824-1831. (Pubitemid 46860271)
2. Repetto L, Fratino L, Audisio RA, et al,. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group For Geriatric Oncology Study. J Clin Oncol 2002; 20: 494-502. (Pubitemid 34072534)
3. Ahles TA, Root JC, Ryan EL,. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 2012; 30: 3675-3686.
4. Ganz PA,. " Doctor, will the treatment you are recommending cause chemobrain? ". J Clin Oncol 2012; 30: 229-231.
5. Matsuda T, Takayama T, Tashiro M, Nakamura Y, Ohashi Y, Shimozuma K,. Mild cognitive declines after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer 2005; 12: 279-287.
6. Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB,. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 2012; 30: 1080-1086.
7. Schilder CM, Seynaeve C, Linn SC, et al,. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study. Psycho-Oncology 2012; 21: 479-487.
8. Nelson CJ, Lee JS, Gamboa MC, Roth AJ,. Cognitive effects of hormone therapy in men with prostate cancer: a review. Cancer 2008; 113: 1097-1106.
9. Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J,. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 2005; 104: 2222-2233. (Pubitemid 41579970)
10. Schilder CM, Seynaeve C, Beex LV, et al,. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol 2010; 28: 1294-1300.
11. Shaw EG, Rosdhal R, D'Agostino RB, et al,. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 2006; 24: 1415-1420. (Pubitemid 46622007)
12. Cole RP, Scialla SJ, Bednarz L,. Functional recovery in cancer rehabilitation. Arch Phys Med Rehabil 2000; 81: 623-627. (Pubitemid 30257686)
13. Ahles TA,. Brain vulnerability to chemotherapy toxicities. Psycho-Oncology 2012; 21: 1141-1148.
14. Kvale EA, Clay OJ, Ross-Meadows LA, et al,. Cognitive speed of processing and functional declines in older cancer survivors: an analysis of data from the ACTIVE trial. Eur J Cancer Care 2010; 19: 110-117.
15. Ootani M, Nara I, Kaneko F, Okamura H,. Construction of a speed feedback therapy system to improve cognitive declines in elderly people with dementia: a preliminary report. Dement Geriatr Cogn Disord 2005; 20: 105-111. (Pubitemid 41191625)
16. Kaneko F, Hirasawa R, Funaki Y, Okamura H,. Effect of speed-feedback exercise using a bicycle ergometer on physical and mental functions among infirm elderly people. Asian journal of Psychiatry 2011; 4: S75.
17. Dubois B, Slachevsky A, Litvan I, Pillon B,. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55: 1621-1626.
18. Nakaaki S, Murata Y, Sato J, et al,. Reliability and validity of the Japanese version of the Frontal Assessment Battery in patients with the frontal variant of frontotemporal dementia. Psychiatry and clinical neurosciences 2007; 61: 78-83. (Pubitemid 46089410)
19. Miki E, Kataoka T, Okamura H,. Clinical usefulness of the Frontal Assessment Battery at bedside (FAB) for elderly cancer patients. Support Care Cancer 2013; 21: 857-862.
20. Mahoney FI, Barthel DW,. Functional evaluation: the Barthel Index. Md State Med J 1965; 14: 61-65.
21. Lawton MP, Brody EM,. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-186.
22. Cella DF, Tulsky DS, Gray G, et al,. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-579. (Pubitemid 23071057)
23. Rowe J, Friston K, Frackowiak R, Passingham R,. Attention to action: specific modulation of corticocortical interactions in humans. Neuroimage 2002; 17: 988-998. (Pubitemid 35317031)
24. Winocur G, Vardy J, Binns MA, Kerr L, Tannock I,. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 2006; 85: 66-75. (Pubitemid 44802737)
25. Joly F, Rigal O, Noal S, Giffard B,. Cognitive dysfunction and cancer: which consequences in terms of disease management? Psycho-Oncology 2011; 20: 1251-1258.